Differential profile of CRF receptor distribution in the rat stomach and duodenum assessed by newly developed CRF receptor antibodies

Journal of Neurochemistry

Volumn 88, Issue 1, 2004, Pages 1-11

  Chatzaki, Ekaterini ^a,c   Murphy, Brian J ^a   Wang, Lixin ^b   Million, Mulugeta ^b   Ohning, Gordon V ^b   Crowe, Paul D ^a   Petroski, Robert ^a   Taché, Yvette ^b   Grigoriadis, Dimitri E ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Antibody; CRF1; CRF2; Parietal; Stomach; Urocortin

Indexed keywords

ANTISERUM; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTIBODY; POLYCLONAL ANTIBODY; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DUODENUM; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; STOMACH; STOMACH ACID SECRETION; STOMACH BLOOD FLOW; STOMACH GLAND; STOMACH MUCOSA; STOMACH PARIETAL CELL; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0346102605     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02078.x     Document Type: Article

References (62)

1. 2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay. Neuropharmacology, 38, 441-448.
2. Asakawa A., Inui A., Ueno N., Makino S., Fujino M. A. and Kasuga M. (1999) Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice [see comments]. Gastroenterology 116, 1287-1292.
3. Baigent S. M. and Lowry P. J. (2000) mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues. J. Mol. Endocrinol. 25, 43-52.
4. Bale T. L., Giordano F. J., Hickey R. P. et al. (2002) Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc. Natl Acad. Sci. USA 99, 7734-7739.
5. Bell F. R. (1979) The relevance of the new knowledge of gastrointestinal hormones to veterinary science. Vet. Sci. Commun. 2, 305-314.
6. Bittencourt J. C., Vaughan J., Arias C., Rissman R. A., Vale W. W. and Sawchenko P. E. (1999) Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J. Comp. Neurol. 415, 285-312.
7. Bradbury M. J., McBurnie M. I., Denton D. A., Lee K. F. and Vale W. W. (2000) Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice. Endocrinology 141, 2715-2724.
8. Bradford M. (1976) A rapid and sensitive method for the quantitation of protein utilizing the principle of protein dye binding.). Anal. Biochem. 72, 148-254.
9. Chatzaki E., Bax C. M., Eidne K. A., Anderson L., Grudzinskas J. G. and Gallagher C. J. (1996) The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor. Cancer Res. 56, 2059-2065.
10. Chatzaki E., Margioris A. N. and Gravanis A. (2002) Expression and regulation of corticotropin-releasing hormone binding protein (CRH-BP) in rat adrenals. J. Neurochem. 80, 81-90.
11. Chatzaki E., Charalampopoulos I., Leontidis C., Mouzas I. A., Tzardi M., Tsatsanis C., Margioris A. N. and Gravanis A. (2003) Urocortin in human gastric mucosa: relationship to inflammatory activity. J. Clin. Endocrinol. Metab. 88, 478-483.
12. Chen R., Lewis K. A., Perrin M. H. and Vale W. W. (1993) Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl Acad. Sci. U S A 90, 8967-8971.
13. Donaldson C. J., Sutton S. W., Perrin M. H., Corrigan A. Z., Lewis K. A., Rivier J. E., Vaughan J. M. and Vale W. W. (1996) Cloning and characterization of human urocortin. Endocrinology 137, 2167-2170. [published erratum appears in Endocrinology 1996 September; 137 (9): 3896].
14. Donaldson C. J., Sutton S. W., Perrin M. H., Corrigan A. Z., Lewis K. A., Rivier J. E., Vaughan J. M. and Vale W. W. (1996) Cloning and characterization of human urocortin. Endocrinology 137, 2167-2170. [published erratum appears in Endocrinology 1996 September; 137 (9): 3896].
15. Enck P. and Holtmann G. (1992) Stress and gastrointestinal motility in animals: a review of the literature. J. Gastrointest. Motil. 1, 83-90.
16. Flores M., Carvallo P. and Aguilera G. (1990) Physicochemical characterization of corticotrophin-releasing factor receptor in rat pituitary and brain. Life Sci. 47, 2035-2040.
17. Grigoriadis D. E. and De Souza E. B. (1988) The brain corticotropin-releasing factor (CRF) receptor is of lower apparent molecular weight than the CRF receptor in anterior pituitary. Evidence from chemical cross-linking studies. J. Biol. Chem. 263, 10927-10931.
18. Grigoriadis D. E., Heroux J. A. and De Souza E. B. (1993) Characterization and regulation of corticotropin-releasing factor receptors in the central nervous, endocrine and immune systems. Ciba Found. Symp. 172, 85-101.
19. Grigoriadis D. E., Lovenberg T. W., Chalmers D. T., Liaw C. and De Souza E. B. (1996) Characterization of corticotropin-releasing factor receptor subtypes. Ann. N Y Acad. Sci. 780, 60-80.
20. Harada S., Imaki T., Naruse M., Chikada N., Nakajima K. and Demura H. (1999) Urocortin mRNA is expressed in the enteric nervous system of the rat. Neurosci. Lett. 267, 125-128.
21. Heymann-Monnikes I., Tache Y., Trauner M., Weiner H. and Garrick T. (1991) CRF microinjected into the dorsal vagal complex inhibits TRH analog- and kainic acid-stimulated gastric contractility in rats. Brain Res. 554, 139-144.
22. Hsu S. Y. and Hsueh A. J. (2001) Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 7, 605-611.
23. Kanamoto K., Urdanda A., Rivier J. and Tache Y. (2002) Intravenous urocortin 11 induced gastroprotection and gastric hyperemia in anesthetized rats: role of CRF receptor 2. Gastroenterology 122, A-13.
24. Kawahito Y., Sano H., Kawata M. et al. (1994) Local secretion of corticotropin-releasing hormone by enterochromaffin cells in human colon. Gastroenterology 106, 859-865.
25. Kawahito Y., Sano H., Mukai S. et al. (1995) Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis. Gut 37, 544-551.
26. Kihara N., Fujimura M., Yamamoto I., Itoh E., Inui A. and Fujimiya M. (2001) Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G406-G419.
27. Kimura Y., Takahashi K., Totsune K. et al. (2002) Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart. J. Clin. Endocrinol. Metab. 87, 340-346.
28. Kishimoto T., Pearse I. I. R. V., Lin C. R. and Rosenfeld M. G. (1995) A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl Acad. Sci. USA 92, 1108-1112.
29. 2gamma receptor. Mol. Endocrinol. 12, 1077-1085.
30. Kozicz T. and Arimura A. (2002) Distribution of urocortin in the rat's gastrointestinal tract and its colocalization with tyrosine hydroxylase. Peptides 23, 515-521.
31. Lenz H. J., Raedler A., Greten H., Vale W. W. and Rivier J. E. (1988) Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous corticotropin-releasing factor. Gastroenterology 95, 1510-1517.
32. 2 receptor. Proc. Natl Acad. Sci. USA 98, 7570-7575.
33. 2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136, 4139-4142.
34. Lovenberg T. W., Liaw C. W., Grigoriadis D. E., Clevenger W., Chalmers D. T., De Souza E. B. and Oltersdorf T. (1995b) Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl Acad. Sci. USA 92, 836-840. [published erratum appears in Proc. Natl Acad. Sci. U S A 1995 June 6; 92 (12): 5759].
35. Lovenberg T. W., Liaw C. W., Grigoriadis D. E., Clevenger W., Chalmers D. T., De Souza E. B. and Oltersdorf T. (1995b) Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl Acad. Sci. USA 92, 836-840. [published erratum appears in Proc. Natl Acad. Sci. U S A 1995 June 6; 92 (12): 5759].
36. Lytras N., Grossman A., Rees L. H., Schally A. V., Bloom S. R. and Besser G. M. (1984) Corticotrophin releasing factor: effects on circulating gut and pancreatic peptides in man. Clin. Endocrinol. 20, 725-729.
37. Maillot C., Million M., Wei J. Y., Gauthier A. and Tache Y. (2000) Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type I receptor in rats. Gastroenterology 119, 1569-1579.
38. Martinez J. A. and Bueno L. (1991) Buspirone inhibits corticotropin-releasing factor and stress-induced cecal motor response in rats by acting through 5-HT1A receptors. Eur. J. Pharmacol. 202, 379-383.
39. Martinez V., Rivier J. and Tache Y. (1999) Peripheral injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats. J. Pharmacol. Exp. Ther. 290, 629-634.
40. Martinez V., Wang L., Rivier J. E., Vale W. and Tache Y. (2002) Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J. Pharmacol. Exp. Ther. 301, 611-617.
41. Martins A. P., Marras R. A. and Guimaraes F. S. (1997) Anxiogenic effect of corticotropin-releasing hormone in the dorsal periaqueductal grey. Neuroreport 8, 3601-3604.
42. Million M., Maillot C., Saunders P., Rivier J., Vale W. and Tache Y. (2002) Human urocortin II, a new CRF-related peptide, displays selective CRF (2)-mediated action on gastric transit in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 282, G34-G40.
43. Monnikes H., Schmidt B. G. and Tache Y. (1993) Psychological stress-induced accelerated colonic transit in rats involves hypothalamic corticotropin-releasing factor. Gastroenterology 104, 716-723.
44. Muramatsu Y., Fukushima K., Iino K. et al. (2000) Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa. Peptides 21, 1799-1809.
45. Nozu T., Martinez V., Rivier J. and Tache Y. (1999) Peripheral urocortin delays gastric emptying: role of CRF receptor 2. Am. J. Physiol. 276, G867-G874.
46. Parkes D. G. and May C. N. (2000) Urocortin: a Novel Player in Cardiac Control. News Physiol. Sci. 15, 264-268.
47. Perrin M., Donaldson C., Chen R., Blount A., Berggren T., Bilezikjian L., Sawchenko P. and Vale W. (1995) Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl Acad. Sci. USA 92, 2969-2973.
48. Perrin M. H., Donaldson C. J., Chen R., Lewis K. A. and Vale W. W. (1993) Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 133, 3058-3061.
49. Radulovic J., Sydow S. and Spiess J. (1998) Characterization of native corticotropin-releasing factor receptor type 1 (CRFR1) in the rat and mouse central nervous system. J. Neurosci. Res. 54, 507-521.
50. Rao S. S., Hatfield R. A., Suls J. M. and Chamberlain M. J. (1998) Psychological and physical stress induce differential effects on human colonic motility. Am. J. Gastroenterol. 93, 985-990.
51. Reyes T. M., Lewis K., Perrin M. H. et al. (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl Acad. Sci. USA 98, 2843-2848.
52. Rohde E., Furkert J., Fechner K., Beyermann M., Mulvany M. J., Richter R. M., Denef C., Bienert M. and Berger H. (1996) Corticotropin-releasing hormone (CRH) receptors in the mesenteric small arteries of rats resemble the (2)-subtype. Biochem. Pharmacol. 52, 829-833.
53. Sanchez M. M., Young L. J., Plotsky P. M. and Insel T. R. (1999) Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J. Comp. Neurol. 408, 365-377.
54. Selye H. (1936) Syndrome produced by diverse nocuous agents. Nature 138, 32.
55. Tache Y., Goto Y., Gunion M., Rivier J. and Debas H. (1984) Inhibition of gastric acid secretion in rats and in dogs by corticotropin-releasing factor. Gastroenterology 86, 281-286.
56. Tache Y., Martinez V., Million M. and Wang L. (2001) Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am. J. Physiol. Gastrointest Liver Physiol. 280, G173-G177.
57. Todisco A., Park J., Lezoche E., Debas H., Tache Y. and Yamada T. (1987) Peripheral acid inhibitory action of corticotropin releasing factor: mediation by nongastric mechanisms. Gastroenterology 92, 919-924.
58. Vale W., Spiess J., Rivier C. and Rivier J. (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213, 1394-1397.
59. Van Pett K., Viau V., Bittencourt J. C. et al. (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428, 191-212.
60. Vaughan J., Donaldson C., Bittencourt J. et al. (1995) Urocortin, a mammalian neuropeptide related to fish urotensin 1 and to corticotropin-releasing factor [see comments]. Nature 378, 287-292.
61. Wang L., Martinez V., Rivier J. E. and Tache Y. (2001) Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1401-R1410.
62. Wong H. C., Walsh J. H., Yang H., Tache Y. and Buchan A. M. (1990) A monoclonal antibody to somatostatin with potent in vivo immunoneutralizing activity. Peptides 11, 707-712.